1-4 of 4
Maarten L. Zandvliet
Close
Sort by
Journal Articles

Universal CD137 Expression upon Activation Allows Efficient Isolation of a Broad Repertoire of Virus-Specific CD8+ and CD4+ T Cells for Adoptive Immunotherapy.

Maarten L. Zandvliet, J.H. Frederik Falkenburg, Inge Jedema, Roelof Willemze, Henk-Jan Guchelaar, Pauline Meij
Journal: Blood
Blood (2008) 112 (11): 2222.
https://doi.org/10.1182/blood.V112.11.2222.2222
Published: 2008
Journal Articles

Generation of Combined CD8+ and CD4+ T Cell Lines with High Specificity for Adenovirus Hexon Epitopes for Adoptive Immunotherapy after Allogeneic Stem Cell Transplantation.

Maarten L. Zandvliet, J.H. Frederik Falkenburg, Louise A. Veltrop-Duits, Marco W. Schilham, Roelof Willemze, Henk-Jan Guchelaar, Pauline Meij
Journal: Blood
Blood (2008) 112 (11): 2225.
https://doi.org/10.1182/blood.V112.11.2225.2225
Published: 2008
Journal Articles

Sequence Dependent Efficiency of Cross-Presentation in MHC Class I Requires Rational Design of Long Synthetic Peptides for Vaccination or Ex Vivo Activation

Maarten L. Zandvliet, J.H. Frederik Falkenburg, Michel G.D. Kester, Arnoud H. de Ru, Peter A. van Veelen, Roelof Willemze, Henk-Jan Guchelaar, Pauline Meij
Journal: Blood
Blood (2008) 112 (11): 3904.
https://doi.org/10.1182/blood.V112.11.3904.3904
Published: 2008
Journal Articles

Generation of GMP-Grade CMV pp65-Specific CD8+ and CD4+ Donor T Cell Lines for Treatment of CMV Reactivation after Transplantation.

Maarten L. Zandvliet, J.H. Frederik Falkenburg, Inge Jedema, Roelof Willemze, Henk-Jan Guchelaar, Pauline Meij
Journal: Blood
Blood (2006) 108 (11): 2931.
https://doi.org/10.1182/blood.V108.11.2931.2931
Published: 2006